Discount rates for flu vaccines for winter 2018 through Londonwide LMCs' Buying Group
Many practices are starting to plan for winter 2018 and are pre-ordering their flu vaccines.
Londonwide LMCs' Buying Group, through our buying partner MidMeds, has negotiated a specially discounted rate for member practices.
The discounted rate of 50% of the normal cost has been offered for Influvac QIV and Generic QIV, the rate has been offered initially until the end of February 2018 by Mylan. There is a 40.3% discount available for FLUAD (adjuvanted Trivalent) offered by Seqirus available until 16 February 2018, a discount of 38.8% will be available after 16 February 2018.
Londonwide LMCs has recently refreshed its buying group service so even if you used the previous buying group arrangement you will need to register if you have not done so since 30 January 2018.
To take advantage of these offers you can contact the suppliers directly:
- Quadrivalent - Mylan
Tel: 0800 358 7468 / Email: flu@mylan.com. - Adjuvanted Trivalent - Seqirus
Tel: 01530 454 288 / Email:flu.salesuk@seqirus.com.
Please state that you are a member of the Londonwide LMCs' buying group when placing your order.
Further information on the rates and terms of this offer is available here.
The Londonwide LMCs' buying group refreshed service, powered by MidMeds and MIAB was launched on 30 January 2018. Please click here for more information.
Following some confusion about ordering flu vaccines NHS England issued this definitive guidance on 5 February 2018.
Please note, Londonwide LMCs is no longer working the LMC Buying Group Federation run by Nottinghamshire LMC.
If you have any questions please contact Ann Ayamah on 020 3818 6250 or ann.ayamah@lmc.org.uk.
Last updated : 06 Jul 2018GP Contract changes – Coronavirus provisions extended (21 Oct 2020)
At the end of September NHS England wrote to practices and commissioners reminding them of the 2020-21 GP Contract changes and announcing announced the extension of some temporary measures introduced...GMC publish new consent guidance (21 Oct 2020)
The GMC have updated their guidance in relation to consent – the guidance comes into effect on 9 November 2020 and can be accessed at the link below: Guidance...Health Select Committee pandemic report (21 Oct 2020)
Amongst other things,Parliament’s Health and Social Care Select Committee called for improvements in referral handling at the primary/secondary care interface, better staff testing (including for GPs and staff) and quoted...Tips of the Month October 2020 (21 Oct 2020)
We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...Londonwide LMCs' October 2020 Newsletter (21 Oct 2020)
...NHS 111 First roll-out (21 Oct 2020)
By 1 December NHS 111 will be able to book appointments at emergency departments (EDs) within all London hospitals. This will coincide with a campaign encouraging patients to contact NHS...Calling all general practice managers, business managers, HR managers, finance managers, operational managers, managing partners and site managers (24 Sep 2020)
As part of our Practice Manager Development project, we are able to offer you an opportunity to take-up a fully...Appraisal resumes and GMC to consider Coronavirus impact during investigations (23 Sep 2020)
NHS England has instructed GPs to resume the appraisal process from 1 October, although this will be in a form which is intended to reduce the amount of paperwork involved,...Coronavirus protection for London general practice (23 Sep 2020)
As the only truly independent voice for London general practice, Londonwide LMCs continues to provide constructive challenge on behalf of GPs, nurses and the whole team in each and every...Guidance
We provide expert guidance for practices in our guidance section, as well as an archive of other materials you may find useful.
GP Support
Contact our GP Support team if you need help or advice.
The team provide professional and pastoral support to GPs and practice teams on a broad range of issues.
follow us on...
